Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

SELL
$14.1 - $19.83 $401,934 - $565,273
-28,506 Reduced 16.97%
139,454 $2.24 Million
Q1 2023

Apr 26, 2023

BUY
$9.09 - $19.45 $1.53 Million - $3.27 Million
167,960 New
167,960 $2.92 Million
Q3 2022

Oct 28, 2022

SELL
$7.86 - $12.91 $372,964 - $612,592
-47,451 Reduced 18.36%
210,992 $1.82 Million
Q2 2022

Aug 04, 2022

BUY
$7.06 - $13.97 $871,514 - $1.72 Million
123,444 Added 91.44%
258,443 $2.11 Million
Q1 2022

May 03, 2022

BUY
$12.15 - $35.28 $724,966 - $2.11 Million
59,668 Added 79.21%
134,999 $1.64 Million
Q4 2021

Jan 31, 2022

BUY
$30.49 - $48.49 $166,018 - $264,028
5,445 Added 7.79%
75,331 $2.57 Million
Q3 2021

Oct 27, 2021

BUY
$41.66 - $52.52 $3,957 - $4,989
95 Added 0.14%
69,886 $3.37 Million
Q2 2021

Jul 23, 2021

SELL
$36.62 - $51.69 $14,721 - $20,779
-402 Reduced 0.57%
69,791 $3.15 Million
Q1 2021

Apr 27, 2021

SELL
$41.56 - $59.88 $161,751 - $233,052
-3,892 Reduced 5.25%
70,193 $3.39 Million
Q4 2020

Feb 03, 2021

SELL
$36.08 - $56.47 $167,375 - $261,964
-4,639 Reduced 5.89%
74,085 $3.99 Million
Q3 2020

Oct 27, 2020

SELL
$33.26 - $40.48 $126,221 - $153,621
-3,795 Reduced 4.6%
78,724 $2.9 Million
Q2 2020

Aug 04, 2020

SELL
$24.21 - $31.02 $270,885 - $347,082
-11,189 Reduced 11.94%
82,519 $2.56 Million
Q4 2019

Jan 31, 2020

SELL
$18.96 - $29.84 $195,136 - $307,113
-10,292 Reduced 9.9%
93,708 $2.74 Million
Q3 2019

Oct 23, 2019

BUY
$19.12 - $26.24 $1.99 Million - $2.73 Million
104,000 New
104,000 $1.99 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.26B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.